By Angel Adegbesan | Bloomberg
Soleno Therapeutics jumped on Thursday after the drugmaker received US approval for its drug to deal with insatiable starvation brought on by a genetic dysfunction.
Shares of the Redwood Metropolis, California-based firm climbed 38% — the largest one-day acquire since September 2023 — to their highest stage in additional than eight years.